High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Cetuximab
Related studies linked through entity extraction aliases.
Pre-op Rectal ChemoRad +/- Cetuximab
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Cetuximab and Concurrent Radio-chemotherapy
- Status
- COMPLETED
- Phase
- PHASE1
Phase I/Randomized Phase II Study of Second Line Therapy With Irinotecan + Cetuximab +/- RAD001 for Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
Docetaxel+Oxali+/-Cetux Met Gastric/GEJ
- Status
- COMPLETED
- Phase
- PHASE2
BIBW 2992 (Afatinib) in Head & Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery
- Status
- UNKNOWN
- Phase
- PHASE2
Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA)
- Status
- COMPLETED
- Phase
- PHASE2
Study Using IMC-A12 (Cixutumumab) With or Without Cetuximab in Participants With Metastatic Colorectal Cancer Who Have Failed a Treatment Regimen That Consisted of a Prior Anti-EGFR Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Induction Chemotherapy Prior to Radio-immunotherapy in Head and Neck Cancer Stage III/IV - a Methodical Trial
- Status
- COMPLETED
- Phase
- NA
FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
- Status
- TERMINATED
- Phase
- PHASE3
Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer (APM4187g)
- Status
- COMPLETED
- Phase
- PHASE1
Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE3